Rational approach to selection and clinical development of TB vaccine candidates

Tuberculosis

Volumn 92, Issue SUPPL.1, 2012, Pages

  Barker, Lew ^a   Hessel, Luc ^b   Walker, Barry ^c  

^a AERAS   (United States)

^b Consultant in Vaccinology ^*  (France)

^c NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Stage gates; Tuberculosis; Vaccines

Indexed keywords

BCG VACCINE;

COMMERCIAL PHENOMENA; DECISION MAKING; DRUG EFFICACY; DRUG MARKETING; DRUG SAFETY; HUMAN; IMMUNOGENICITY; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; QUALITY CONTROL; REVIEW;

EID: 84858734598     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/S1472-9792(12)70009-4     Document Type: Article

References (1)

1. RG Cooper Perspective: The Stage-Gate Idea-to-Launch Process - Update, What's New, and NexGen Systems J Prod Innov Manag 25 2008 213 232 (Pubitemid 351430387)